Returns Chart

Key Stats

Customize
Expense Ratio Total Assets Under Management Dividend Yield Turnover Ratio
0.64% 9.304B 0.00% 7.00%
1 Year Fund Level Flows 1 Year Total Returns (Daily) Annualized All Time Total Returns (Daily) Max Drawdown (All)
-1.693B 12.34% Upgrade Upgrade

Basic Info

Investment Strategy
The investment seeks to provide long-term capital appreciation. The fund invests primarily in the common stocks of U.S. companies, emphasizing those companies with prospects for rapid earnings growth. It may invest in stocks across all market sectors and market capitalizations and has historically invested significant portions of its assets in mid- and small-capitalization companies.
General
Security Type Mutual Fund
Oldest Share Symbol POAGX
Equity Style Mid Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Mid-Cap Growth
Category Index Russell Mid Cap Growth TR USD
Prospectus Objective Aggressive Growth
Fund Owner Firm Name PRIMECAP Odyssey Funds
Prospectus Benchmark Index
S&P 500 TR USD 100.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Alfred Mordecai 15.84 yrs
Joel Fried 15.84 yrs
Theo Kolokotrones 15.84 yrs
M. Ansari 8.39 yrs
James Marchetti 5.84 yrs

Net Fund Flows Versus Category

View Net Fund Flows. Upgrade now.
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
 
80.00B
60.00B
40.00B
20.00B
0
-20.00B
1 Month
% Rank: --
-- Category Low
-- Category High
1 Year
% Rank: 98
-1.693B
-4.185B Category Low
3.612B Category High
3 Months
% Rank: --
-- Category Low
-- Category High
3 Years
% Rank: --
-- Category Low
-- Category High
6 Months
% Rank: --
-- Category Low
-- Category High
5 Years
% Rank: --
-- Category Low
-- Category High
YTD
% Rank: --
-- Category Low
-- Category High
10 Years
% Rank: --
-- Category Low
-- Category High
As of August 31, 2020

Performance Versus Category

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
Total Return (NAV)
--
--
--
--
--
--
--
--
Category Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Cat (NAV)
--
--
--
--
--
--
--
--
As of September 23, 2020. Returns for periods of 1 year and above are annualized.

Annual Total Returns Versus Peers

Edit comparables
Name
2013
2014
2015
2016
2017
2018
2019
YTD
54.88%
16.55%
4.56%
11.73%
33.59%
-6.93%
23.50%
3.03%
32.39%
13.69%
1.38%
11.96%
21.83%
-4.38%
31.49%
1.59%
37.87%
13.69%
3.17%
2.72%
21.50%
-6.96%
36.59%
7.91%
49.11%
6.10%
4.50%
7.79%
31.49%
4.04%
37.71%
30.44%
--
7.64%
-3.49%
16.77%
18.26%
-9.02%
27.95%
0.31%
34.57%
11.47%
2.06%
7.50%
24.72%
-3.11%
37.90%
5.97%
As of September 23, 2020.

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (9-23-20) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 21.59
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of June 30, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of June 30, 2020

Asset Allocation

As of June 30, 2020.
Type % Net % Long % Short
Cash 2.80% Upgrade Upgrade
Stock 97.01% Upgrade Upgrade
Bond 0.00% Upgrade Upgrade
Convertible 0.00% Upgrade Upgrade
Preferred 0.19% Upgrade Upgrade
Other 0.00% Upgrade Upgrade

Top 10 Holdings

Name % Weight Price % Change
Splunk Inc 3.92% 175.89 -0.90%
Seattle Genetics Inc 3.89% 179.43 0.09%
Sony Corp ADR 3.62% 77.90 0.74%
Micron Technology Inc 3.18% 49.53 -0.64%
Abiomed Inc 2.91% 262.44 0.90%
Nektar Therapeutics 2.79% 18.03 -4.65%
MarketAxess Holdings Inc 2.60% 452.14 0.60%
Biomarin Pharmaceutical Inc 2.60% 76.67 -2.24%
Biogen Inc 2.29% 270.18 -0.74%
Chegg Inc 2.24% 67.98 -2.82%

Fees & Availability

Fees
Actual 12B-1 Fee --
Actual Management Fee Upgrade
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No
Purchase Details
Open to New Investors No
Open to Existing Investors Yes
Minimum Initial Investment Upgrade
Minimum Subsequent Investment Upgrade

Basic Info

Investment Strategy
The investment seeks to provide long-term capital appreciation. The fund invests primarily in the common stocks of U.S. companies, emphasizing those companies with prospects for rapid earnings growth. It may invest in stocks across all market sectors and market capitalizations and has historically invested significant portions of its assets in mid- and small-capitalization companies.
General
Security Type Mutual Fund
Oldest Share Symbol POAGX
Equity Style Mid Cap/Growth
Fixed Income Style --
Broad Asset Class US Equity
Broad Category Equity
Category Name Mid-Cap Growth
Category Index Russell Mid Cap Growth TR USD
Prospectus Objective Aggressive Growth
Fund Owner Firm Name PRIMECAP Odyssey Funds
Prospectus Benchmark Index
S&P 500 TR USD 100.0%
Broad Asset Class Benchmark Index
^SPXTR 100.0%
Manager Tenure
Alfred Mordecai 15.84 yrs
Joel Fried 15.84 yrs
Theo Kolokotrones 15.84 yrs
M. Ansari 8.39 yrs
James Marchetti 5.84 yrs

Fundamentals

General
Distribution Yield Upgrade
Dividend Yield TTM (9-23-20) 0.00%
30-Day SEC Yield --
7-Day SEC Yield --
Number of Holdings Upgrade
Stock
Weighted Average PE Ratio 21.59
Weighted Average Price to Sales Ratio Upgrade
Weighted Average Price to Book Ratio Upgrade
Weighted Median ROE Upgrade
Weighted Median ROA Upgrade
Forecasted Dividend Yield Upgrade
Forecasted PE Ratio Upgrade
Forecasted Price to Sales Ratio Upgrade
Forecasted Price to Book Ratio Upgrade
As of June 30, 2020

Growth Estimates

Forecasted 5 Yr Earnings Growth Upgrade
Forecasted Book Value Growth Upgrade
Forecasted Cash Flow Growth Upgrade
Forecasted Earnings Growth Upgrade
Forecasted Revenue Growth Upgrade
As of June 30, 2020

Fund Details

Key Dates
Inception Date 11/1/2004
Last Annual Report Date 10/31/2019
Last Prospectus Date 2/28/2020
Attributes
Enhanced Index Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No